chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had headache, joint and body aches. The the night of the 2nd vaccination, I was awoken to what felt like electrical jolts in my body. One time I woke up jumping so high of my bed that it felt like I was being tased. I woke up the next morning and felt like electrical currents were running through my body. My right hand had a tremor too
Bright red flat rash over chest noticed after taking shower approximately 24 hours after receiving vaccine. Approximately 40 hours after receiving vaccine began to itch all over body. Took CLARITIN. After shower approximately 48 hours after vaccine noticed flat rash over chest, up to neck. Light rash on arms and thighs. After 56 hours, experienced vertigo on standing. Rash on arms and legs gone and chest rash became lighter in color. After 72 hours rash mostly gone. Vertigo gone.  Itching remaining on chest for one week.
ZOSTAVAX administered 8-25-10; on 9-3-10 pt developed burning epigastric pain, persistent, not responding to DEXILANT and CARAFATE. Upper endoscopy 9-16-10: mild gastritis. Abd. ultrasound neg. 9-10-10 developed fever blister upper lip & nose. 9-17-10 developed vesicle left lower eyelid.
The patient reports that when she received her shot there didn't seem to be anything out of the ordinary.  No excessive pain during the process and a normal amount of ache afterwards, however the muscle pain did not subside and 3-4 days ago, about 2 weeks after the shot, it began to worsen and travel down the arm. I advised the patient to be seen by a doctor to determine the source of the pain.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. On an unknown date, unspecified number of patients were vaccinated with doses of Oral, ROTATEQ (dose and lot# was unknown) which were improperly stored. The outcome of the events was unknown. This is one of several reports received form the same reporter. Additional information is not expected as reporter is not willing to be contacted.
I started having symptoms of exhaustion of congestion and fatigue January 01, 2022. Then I couldn't breathe and I had a very high respiratory rate. My O2 was 88. It was the worst I ever felt. I had body pains, loss taste and smell, severe headache, and was not able to breathe. I did have fever and chills. I don't think the fever got higher than 103.  On 01/05/2022 I tested positive after taking two COVID tests that were negative on 01/03 and 01/04. I had a tele-health visit I was prescribed amoxicillin and that made me vomit constantly. I contacted them the next day and I went off the antibiotic. I can't take most medications so I had to wait it out. I stayed hydrated and moving. My O2 went up and down. I was also prescribed a steroid on 01/05/2022 that I did not stop and I do think that helped and kept me out of the hospitals. It was about 5 weeks before I could breathe and most symptoms subsided but I still do not have taste or smell or my stamina.
This case was reported by a healthcare professional, via Merck, and described the occurrence of diffuse swelling of arm following injection in a male subject of unspecified age who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (Dtpa, manufacturer unspecified) for prophylaxis. Co-suspect vaccine included injectable poliomyelitis vaccine inactivated, manufacturer unspecified given on an unspecified date. On an unspecified date the subject received an unspecified dose of Dtpa (unknown). At an unspecified time after vaccination with Dtpa and polio vaccine, the subject developed a diffuse swelling of the injected arm. The swelling went from his mid to upper foreman and was red and non-tender. On an unspecified date, the subject sought medical attention. At the time of reporting the outcome of the events were was unspecified.
COVID-19 PCR test: Result: Positive; COVID-19 PCR test: Result: Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 67-year-old female patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Lot number: EK9231) intramuscular, in left arm, on 02Feb2021 as dose 2, single (Lot number: EL3247), in left arm, on 29Sep2021 as dose 3 (booster), single (Lot number: FF2589), in left arm and on 31Mar2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "Depression" (unspecified if ongoing); "a lot of trouble swallowing" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE taken for hypertension; LOSARTAN oral taken for hypertension; ESCITALOPRAM oral taken for depression. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Aug2022, outcome "unknown" and all described as "COVID-19 PCR test: Result: Positive". The event "covid-19 pcr test: result: positive" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Aug2022) Positive; (02Aug2022) Positive. Additional information: Patient tested positive for Covid earlier this week, was prescribed Paxlovid (Lot: FW4118 and Expiry: Feb2023) at 3 tablets twice a day by mouth for 5 days  earlier today, and has now picked up the medication but has not yet started.  She has a lot of trouble swallowing, and she knows that it can't be crushed or chewed.  She'll never be able to get these down. Her pharmacist said she had to swallow them whole.  If she does that, she will end up throwing them up and the medication won't help her at all. Patient is fully vaccinated and boosted and has Covid-19 on 01Aug2022. Patient assumes she has the new Covid-19 variant because she has had all of her vaccines and she is boosted as well. She is fatigued from the Covid.
This spontaneous report was received from a registered nurse concerning an unknown number of patient of unknown age and gender that were vaccinated with a dose of (Merck) (PROQUAD) (dose, dose number, lot number, expiration date and route were not reported), that was improperly stored. No adverse effect reported. Medical history and concurrent conditions were not reported. Co-suspect and concomitant therapies were not reported. This is one (1) of eight (8) reports from the same reporter. Additional information has been requested.
As background, I was diagnosed with atrial fibrillation in November 2017, and had a cardioversion in January 2018. My heart stayed in sinus rhythm for over three years and was in sinus rhythm when I received my second Pfizer shot. A few days after the shot, I experienced headaches, and my pulse was throbbing in my left temple. It was apparent that the pulse was not in rhythm, which was confirmed by both my primary physician and my cardiologist. Perhaps the shot triggered the recurrence of a-fib, or perhaps it was a coincidence. A cardioversion on March 30 was successful. Note: a-fib recurred again on August 1. Another cardioversion on August 20 was successful. Heart is currently in sinus rhythm.
pt recvd vax & devel a fever of 102 which lasted for 24 hrs;
On 27 April 2009 he received AVA #2 to left deltoid. He again experienced site burning and soreness. Within 6-8 hours he was awakened from sleep with diffuse muscle aches, nausea and a headache. He was able to return to sleep. Within 12 hours post vaccination (28 Apr 09) he awoke complaining of paresthesia to lateral aspect of his right knee extending anteriorly down calf to dorsum of right foot ("along L5 nerve pattern"). He described this paresthesia as pins and needles or a buzzing sensation with no weakness or loss of sensation. He had been in the gym and undergoing physical therapy (PT) for lower back pain and attributed this discomfort to his exercises. 29 April 2009 (day 2) he awoke with paresthesia to both right and left lateral lower legs (L5 distribution pattern as above R>L) down to dorsum of both feet with lower back pain (3/10). He used MOBIC for pain with minimal relief. About day 4 he denied any myalgia, headache or nausea, but he was treated with a MEDROL dose pack for persistent paresthesia with partial relief (eased but did not eliminate). May 2009 PT notes report improvement in LBP (2/10) with traction treatment and decrease in "numbness/tingling" in right lateral calf and foot; however patient stated he stopped traction because symptoms were worse. 2009 Neurological examinations were normal. Review of Sept-Oct 2008 c-spine x-rays and MRI documented C5-7 central canal stenosis and degenerative disc disease and facet arthritis. (No lumbar studies available - was in theater). Paresthesia complaints persisted unchanged (denied numbness or weakness) until 04 July 2009 when he awoke with a strong stiff neck pain that he could not stretch out. O5 July 2009 he noted first bilateral upper extremity paresthesia (numbness and tingling) along ulnar nerve-C8 distribution pattern and later perineal-perianal tingling (no bowel-bladder incontinence) with spastic feelings in feet. Neck pain and bilateral upper extremity paresthesia worsened with flexion and extension of neck (such as bending over patients intubating or doing other procedures). 09 July 2009 exam noted 2 beats clonus bilaterally with L>R UE paresthesia. Spinal surgeon suspected central HNP, provided MEDROL dose pack and medevaced him to back. Patient advised "genital" paresthesia resolved within 1 1/2 weeks after using MEDROL with marked decrease in UE/LE paresthesia. However extremity paresthesia did not fully resolve. As of 11 Aug 2009, he continues to experience moderate to severe neck > lower back pain described as a stiff annoying aching (5/10) discomfort to posterior neck region. He has infrequent paresthesia at rest, experiencing paresthesia to all four extremities mainly with lifting and stretching. His paresthesia occurs with the pain and is described as a "burning feeling" lasting 30 seconds. His SF36 identified limitations with vigorous activities (running, lifting heavy objects) and with climbing several flights of stairs, kneeling, bending or stooping due to pain (not paresthesia).
Patient received 1st dose of Pfizer Covid19 vaccine today at the Health Department at approx 10:56 AM; pfizer lot number EN5318. Patient has history of feeling 'flushed' after paxil, sulfa, flexeril, codeine; no history of anaphylaxis. Patient alerted the guardsman at 11:09AM that she was experiencing swelling and burning on her face and lips. Nursing and medic staff responded and observed swelling over her right eye and cheek. The medic reported a significant increase in swelling from her pre-vaccinated appearance. BP 118/76. EMS already on site. Epi 0.5mg 0.5ml (Lot 339384) administered RD IM and Benadryl 50mg IM LD administered at 11:11 AM. EMS called for 2nd transport vehicle and arrived at 11:23AM and assumed care of patient. Patient transported to hospital. Called patient on 2/11/2021. Patient stated feeling better. Stayed at hospital and was observed for 4 hours. IV and oral Prednisone given. Still has some facial swelling. PCP recommends not getting second dose.
This case was reported by a consumer (GSK employee reporting on the child of a friend) and described the occurrence of narcolepsy in a child female subject who was vaccinated with influenza virus vaccine (Flu vaccine, GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Flu vaccine (unknown). At an unspecified time after vaccination with Flu vaccine, the subject experienced narcolepsy symptoms. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the event was unspecified.
Patient received vaccine at 10:35am, was observed for 15 minutes then returned home with family. Patient began to not feel well,  experienced cardiac arrest as witnessed by son, was taken to hospital Emergency Department where she expired at 12:50pm.
*****************COVID BREAKTHROUGH CASE***************************** I was on a cruise ship which is where I  contracted COVID. I began felling sick May 7, I thought it was allergies to pollen. Some of the other people on the ship had COVID so I tested myself I was positive (PCR) Monday the 9th. Called into my doctor and told me to treat the symptoms. Main Symptoms: Fatigue; Minor Congestion. The worst congestion was the 16th.
Shortly after getting the shot I felt sick for a week. Within a few hours of my vaccine my arm was really swollen. my arm got really hot and the injection site was very red and blotchy. It was area about three inches around. It was a little painful. It lasted over a week before I consulted with the doctor. I was given antibiotics and it got much better, but it was still visible after three weeks when I got the second shot. I was given the second shot in the other arm. I felt sick for one day but I was a little better after that with a low grade fever for one week. Second shot Lot # 013M20A
Diagnosed w/ Thyroid Cancer 1 week after vaccine, started with sore throat, shooting pain into ear whenever you swallow. No issues before the second dose, and then things suddenly manifested. Thyroid has since been removed, plan is to start chemotherapy soon (iodine treatment, has not begun yet). Hospitalized for several days
Woke up with severe urticaria on day 3. Hives all over my body
MD diagnosed with Covid toes post vaccine- pt reports having Bilateral toe discoloration with ulcers
Patient is 35 years old with past medical history of plantar fasciitis presented to the hospital with a chief complaint of shortness of breath associated with sore throat that has been worsening over the last 2 days.  Patient has noticed multiple wheezing nonproductive cough over the last couple days as well.  Patient was found to have COVID in the ER.  When seen, patient continues to have shortness of breath.  Otherwise patient has no fever, chills, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, difficulty with urination,   Clinical Summary Patient's work of breathing secondary to covid infection and asthma exacerbation improved with antibiotics, dexamethasone, and remdesivir.  Patient did no
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 25-Feb-2022, the patient received third dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date).    No concomitant medication was reported.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
Choke; Achiness; Chills; Headache; Fatigue; This is a spontaneous report from a contactable consumer (patient's mother). The reporter reported for her two daughters, this is the second daughter report. A 19-year-old female patient received 2nd dose of meningococcal group b rlp2086 (TRUMENBA, lot# CH2637, expiration date: 28Feb2022, NDC number: 0005010005), via an unspecified route of administration on 21Aug2020 11:30 at single dose for Immunization/Meningitis B. Medical history and concomitant medications were none. The patient experienced choke, achiness, chills, headache, fatigue on 21Aug2020 15:00. And she was still in bed. Ibuprofen and acetaminophen, tylenol was given to the patent after events. The outcome of event was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020326661 Same reporter/drug, similar event, different patient
developed a lump at the injection site; This spontaneous report was received from a pharmacist regarding herself of an unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. She reported that she was diagnosed with low titers of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) as part of a work physical. On an unknown date, 4 weeks ago(approximately in April 2019), she was given a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) with lot number R030812 and expiry date 24-OCT-2020(also reported as 24-OCT-2019) route via subcutaneous for immunization to correct the low titers and she had since developed a lump at the injection site(vaccination site mass). No treatment was given for the lump. The outcome of vaccination site mass was reported as not recovered. Causality assessment was not provided. No PQC found.
Chills, body aches, fever, weakness in legs, fatigue for 24 hours. Started about 12 hours after second dose.
Within 30 mins. a 2" diameter, hard, red, hot, painful lump appeared at the injection site.  It was still there after several hours, so I was advised to treat my son with children's motrin.  I gave him motrin daily for 4 days at which time the lump disappeared. 10 days after the vaccination, my son developed a severe case of hives--large, raised, itchy blotches all over his body.  I treated him with Benadryl but the hives kept recurring every few hours.  After a few days of hives, I brought him to the allergist who prescribed Zyrtec and Zantac 2x a day for 1 month.  This treatment controlled the hives until my son missed 2 doses (2 weeks after the treatment was begun) and hives recurred.  The treatment was resumed and continued for the remainder of the month.  When the treatment ended the hives did not recur.
Patient and younger sibling in room with mother for the flu vaccine. The room was somewhat chaotic with children running around and patient and sibling close to the same size so 0.25ml dose was given to the patient who was 3years 2months of age and she needed to get the 0.5ml dose.
wheezing and swelling of the airway; coughing and nasal stuffiness; coughing and nasal stuffiness/ swelling of the nasal mucosa; wheezing and swelling of the airway; This spontaneous report was received from a physician and refers to a 4-year-old male patient. The patient had no concurrent conditions, medical history, concomitant medications and drug reactions or allergies.  On 11-JUN-2019, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # R035700, expiry date: 09-DEC-2020 (dose, route of administration and anatomical location were not provided) and with a dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot # R035222, expiry date: 04-DEC-2020 (dose, route of administration and anatomical location were not reported), reconstituted with sterile diluent (dose, route of administration, lot #, expiry date and anatomical location were not provided), for routine immunization.   On 11-JUN-2019, within 5 minutes after vaccination, the patient experienced coughing and nasal stuffiness. Physician stated that upon examination the patient had swelling of nasal mucosa. The reporter also stated that when she examined the patient on the same date prior to vaccination, he did not have any swelling of the nasal mucosa while in the doctor's office. The patient received unspecified nasal drops for the swelling of the nasal mucosa. The patient then experienced wheezing and swelling of the airway, while still in doctor's office. The physician stated that the patient was administered an age appropriate dose of epinephrine and albuterol nebulizer treatment. The emergency number was called while the patient was still in the doctor's office. It was reported that the patient improved while in the office. He was transported via ambulance to the emergency room and was observed for 4 hours. No lab diagnostics or studies were performed.  The patient recovered from the events on 11-JUN-2019. The relatedness between the events and suspect therapies were not provided. The reporter requested lot checks for both vaccines.  The reporter considered the event of swelling of the airway as life threatening.  Upon internal review, the event of swelling of the airway was considered to be medically significant.
9/13/22, 07:30 am: Received Covid vaccination 9/14/22, 01:15 am: Patient had a seizure lasting approx 30 min. Biting tongue, lips, contractions of muscles, loss of consciousness.                     02:00 am:  Transported to hospital by ambulance                      04:00 pm:  Discharged home.
Breakthrough case admission after three doses Pfizer 2/18/21 no lot# recorded Pfizer 3/11/21 No lot# recorded Pfizer 6/10/22 Lot# FN2908